Guidelines for the management of COPD
46 results
1 - 46
Guidelines for the management of COPD
Summary of GOLD guideline for COPD
Guidelines for COPD (ACP)
Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care
Chronic obstructive pulmonary disease (COPD)
Amox-clavulanate during COPD exacerbations decreases Sx and delays subsequent exacerbations
Triple inhaled therapy for COPD effective for selected patients
Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD)
Canadian Thoracic Society guidelines for pharmacotherapy of stable chronic obstructive pulmonary disease
Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
Methylxanthines for exacerbations of chronic obstructive pulmonary disease
Tiotropium versus placebo for chronic obstructive pulmonary disease
Self‐management for bronchiectasis
Proton pump inhibitors for chronic obstructive pulmonary disease
Aclidinium bromide for stable chronic obstructive pulmonary disease
Action plans for chronic obstructive pulmonary disease
Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
Allergic contact dermatitis
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Speech and language therapy for management of chronic cough
Pneumococcal vaccines for children and adults with bronchiectasis
Oxygen therapy in the pre‐hospital setting for acute exacerbations of chronic obstructive pulmonary disease
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
Low back pain
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
Non‐invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease
